Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Kennedy-Wilson Holdings, Inc. amended 6.00% Series C Cumulative Perpetual Preferred Stock and Warrant Purchase Agreement with affiliates of Fairfax Financial Holdings Limited (collectively with such affiliates, Fairfax) (effective 2023-12-06).
- Action
- amendment
- Agreement
- equity purchase
- Counterparty
- affiliates of Fairfax Financial Holdings Limited (collectively with such affiliates, Fairfax)
- Effective
- 2023-12-06
Exact text from the filing
On December 6, 2023, Kennedy-Wilson Holdings, Inc. (the “Company”) and certain affiliates of Fairfax Financial Holdings Limited (collectively with such affiliates, “Fairfax”) entered into an amendment to that certain 4.75% Series B Cumulative Perpetual Preferred Stock and Warrant Purchase Agreement (the “Series B SPA”), dated February 23, 2022, by and among the Company and certain Fairfax affiliates, and an amendment to that certain 6.00% Series C Cumulative Perpetual Preferred Stock and Warrant Purchase Agreement (the “Series C SPA”, together with the Series B SPA, the “SPAs”), dated June 4, 2023, by and among the Company and certain Fairfax affiliates, to update the standstill provisions in each of the SPAs.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Kennedy-Wilson Holdings, Inc. amended 4.75% Series B Cumulative Perpetual Preferred Stock and Warrant Purchase Agreement with affiliates of Fairfax Financial Holdings Limited (collectively with such affiliates, Fairfax) (effective 2023-12-06).
- Action
- amendment
- Agreement
- equity purchase
- Counterparty
- affiliates of Fairfax Financial Holdings Limited (collectively with such affiliates, Fairfax)
- Effective
- 2023-12-06
Exact text from the filing
On December 6, 2023, Kennedy-Wilson Holdings, Inc. (the “Company”) and certain affiliates of Fairfax Financial Holdings Limited (collectively with such affiliates, “Fairfax”) entered into an amendment to that certain 4.75% Series B Cumulative Perpetual Preferred Stock and Warrant Purchase Agreement (the “Series B SPA”), dated February 23, 2022, by and among the Company and certain Fairfax affiliates, and an amendment to that certain 6.00% Series C Cumulative Perpetual Preferred Stock and Warrant Purchase Agreement (the “Series C SPA”, together with the Series B SPA, the “SPAs”), dated June 4, 2023, by and among the Company and certain Fairfax affiliates, to update the standstill provisions in each of the SPAs.
View on SEC.gov